Skip to content
Review Open access

Artificial intelligence in clinical trials—state of the evidence, gaps, and next steps

Sep 2026 · EClinicalMedicine · Vol 100 · 0 citations · 78 references
Medicine

TL;DR

This manuscript defines AI-as-intervention as AI whose output is itself part of the assigned clinical intervention being evaluated for its effect on participant care or outcomes, and AI-for-trial-operations as AI used to support trial design, conduct, or analysis without itself constituting the treatment under study.

Abstract

Summary Artificial intelligence (AI) affects clinical trials in two distinct but overlapping ways: as the intervention under evaluation and as infrastructure supporting trial design, recruitment, monitoring, endpoint assessment, analysis, and reporting. In this manuscript, we define AI-as-intervention as AI whose output is itself part of the assigned clinical intervention being evaluated for its effect on participant care or outcomes, and AI-for-trial-operations as AI used to support trial design, conduct, or analysis without itself constituting the treatment under study. This is an important distinction because AI-as-intervention generally requires prospective clinical evaluation with prespecified estimands, prospectively governed model behaviour, and protocol-level oversight, whereas AI-for-trial-operations is often judged by workflow accuracy, impact of the decision, transportability, and safety under real-world constraints, although some uses, such as endpoint support or inferential modelling, may also require similarly explicit change control and oversight. Using this distinction as an analytical framework rather than as a division into separate parts, we examine how AI can improve each phase of the clinical-trial lifecycle, what evidence currently supports these applications, what limitations constrain their validity and transportability, and what methodological and governance safeguards are required. We synthesise evidence across safety, efficacy, operational risk prediction, network medicine, digital health technologies, retrieval-augmented generation, and agentic workflows, while aligning the discussion to ICH E6(R3), ICH E9(R1), and emerging structured-protocol standards. Funding AAA was partly supported by the Institute of Precision Medicine (17UNPG33840017) from the AHA, the RICBAC Foundation, and 10.13039/100000002NIH grants R01HL173935-01, 1 R01 HL161008-01.

Read PDF

Similar papers

Review Open access Sep 2026

State of clinical AI in 2026

Abstract Clinical artificial intelligence (AI) has advanced rapidly, with frontier large language models now matching or exceeding physician performance on simulated diagnostic reasoning and clinical decision-support tasks. Yet adoption has outpaced the evidence base: fewer than 5% of cleared U.S. Food and Drug Adminis...

J. Worth, Anastasia Perez, David Wu et al. · 1 citation
#artificial intelligence Review Aug 2026

AI Morbidity and Mortality: A Framework for Clinical AI Failure Review

AI Morbidity and Mortality (AI M&M) is intended to complement, rather than replace, model monitoring, patient safety reporting, and regulatory oversight by converting individual AI-in-workflow failures into actionable institutional learning.

Paulius Mui, Dean F. Sittig, Steven Labkoff et al. · 0 citations
Sep 2026

[Accuracy alone is not enough: cognitive safety of artificial intelligence in medicine.]

Cognitive safety is proposed here as a longitudinal property of the clinician-AI-organization sociotechnical system: its capacity to support or improve clinical performance without eroding independent hypothesis generation, uncertainty calibration, reasoned dissent, metacognitive control, and resilient performance when...

S. Corrao · 0 citations
#software testing Review Sep 2026

Agentic AI in Medicine: Challenges for Responsible Development and the Case for Clinical Testing Harnesses

It is argued that each of the four challenges facing responsible development is addressed by a clinical testing harness: a structured evaluation environment comprising scenario libraries built from clinical edge cases, full-trajectory observability, explicit escalation testing, and staged evidence thresholds tied to sc...

E. Waisberg, Joseph W. Guarnieri · 1 citation
#large language models Review Open access Sep 2026

Advances, Risks, And Implementation Challenges of Artificial Intelligence as A Force Multiplier for Clinical Decision Making and Health System Efficiency

The central argument is that the value of clinical artificial intelligence is determined less by model accuracy in isolation than by the quality of the sociotechnical system into which a model is placed: governance, workflow integration, monitoring, and the preservation of meaningful human oversight.

Lucky Ilodigwe · 1 citation
Review Open access 2026

Agentic AI in Healthcare: Current Applications, Challenges, and Future Directions

Overall, agentic AI signals a shift toward adaptive, clinician-supervised, and collaborative healthcare systems capable of delivering more efficient, personalized, and resilient care, contingent on systematically resolving technical, evidentiary, and governance challenges.

Noura M. Alotaibi · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.